Safety after BBIBP-CorV (Sinopharm) COVID-19 Vaccine in Adolescents Aged 10–17 Years in Thailand

Coronavirus disease 2019 affected child health and impacted learning because of the resulting onsite school closures. This prospective cohort study included children aged 10–17 who received two 4 µg doses of BBIBP-CorV administered intramuscularly 21–28 days apart. To assess vaccine safety, 36,808 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Thonginnetra, Saraiorn, Tawinprai, Kriangkrai, Niemsorn, Krongkwan, Promsena, Pathariya, Tandhansakul, Manunya, Kasemlawan, Naruporn, Ruangkijpaisal, Natthanan, Banomyong, Narin, Phattraprayoon, Nanthida, Rangkakulnuwat, Pisuttikan, Vanichsetakul, Preeda, Ungtrakul, Teerapat, Wittayasak, Kasiruck, Thonwirak, Nawarat, Soonklang, Kamonwan, Mahanonda, Nithi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612063/
https://www.ncbi.nlm.nih.gov/pubmed/36298630
http://dx.doi.org/10.3390/vaccines10101765

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9612063/
https://www.ncbi.nlm.nih.gov/pubmed/36298630
http://dx.doi.org/10.3390/vaccines10101765

Ejemplares similares